Twist Bioscience Corporation (NASDAQ: TWST) reported Q4 EPS of ($0.84), $0.05 worse than the analyst estimate of ($0.79). Revenue for the quarter came in at $38 million versus the consensus estimate of $37.02 million.

GUIDANCE:

Twist Bioscience Corporation sees FY2022 revenue of $183-193 million, versus the consensus of $131.11 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.